Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein InvasionMinke He, Ming Shi, Li Xu et al.|JAMA Oncology|2019Cited by 559
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinomaMinke He, Ming Shi, Run-Bin Liang et al.|Therapeutic Advances in Medical Oncology|2021Cited by 216
Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trialZhiCheng Lai, Ming Shi, Minke He et al.|European Journal of Cancer|2022Cited by 154
One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinomaZhiCheng Lai, Ming Shi, YeXing Huang et al.|BMC Medicine|2022Cited by 35
Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular CarcinomaYu-Jie Xu, QiJiong Li, ZhiCheng Lai et al.|Technology in Cancer Research & Treatment|2021Cited by 34